Persistent Supravenous Erythematous Eruption (PSEE): A scoping review on an adverse effect related to Docetaxel infusion. RSD [Internet]. 2022 Apr. 3 [cited 2026 Feb. 13];11(5):e21111527974. Available from: https://rsdjournal.org/rsd/article/view/27974